This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Human Immunodeficiency Virus (HIV)-associated Neurocognitive Disorders (HAND) is the mayor cause of dementia in young adults and is characterized by increased neuronal death via a cascade of events related to oxidative stress, mitochondrial damage, and apoptosis. The objective of this proposal is to study the neuroprotective potential of estrogen and fluoxetine during HAND. No studies exist investigating the changes in the neuronal proteome during HAND that may lead to a better understanding of the mechanisms of action of estrogen and fluoxetine. We propose to use an in-vitro model of neurotoxicity simulating HAND by challenging cell cultures with cerebrospinal fluid (CSF) samples from the Hispanic-Latino Longitudinal Women Cohort repository. We hypothesize that estrogen and fluoxetine will mediate neuroprotection by enhancing mechanisms of cell survival, such as reduction/oxidation pathways and mitochondrial integrity. Our first objective is to establish an in-vitro model of neurotoxicity at University of Puerto Rico Medical Science Campus. This will be accomplished by transferring techniques already set in place at Johns Hopkins University School of Medicine. We will validate the neurotoxic potential of CSF from women in our cohort diagnosed with HAND. This will be accomplished by measuring neuronal death using neurotoxic assays. We will then test the neuroprotective potential of estrogens and fluoxetine by pretreatment in neuronal cells when challenged with CSF of HAND patients. This will also be accomplished by measuring neuronal death using neurotoxic assays after pretreatment with neuroprotectors. CSF from non-demented HIV-seropositive patients will be used as controls. Finally, in an attempt to understand the mechanisms of neuroprotection of estrogens and fluoxetine, we will investigate changes in the neuronal proteome mediated by these two compounds using novel proteomics techniques such as two-dimensional differential in-gel expression and tandem mass spectrometry. The short-term goal of this proposal is to develop neurotoxic models for the characterization of these and other compounds with potential for neuroprotection in Hispanic women with HAND. The long-term goal is to generate preliminary data for a National Institute of Health (NIH) K award proposal submission by the PI in translational research.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Exploratory Grants (P20)
Project #
5P20RR011126-15
Application #
7959668
Study Section
National Center for Research Resources Initial Review Group (RIRG)
Project Start
2009-07-01
Project End
2010-06-30
Budget Start
2009-07-01
Budget End
2010-06-30
Support Year
15
Fiscal Year
2009
Total Cost
$37,380
Indirect Cost
Name
University of Puerto Rico Med Sciences
Department
Type
Schools of Medicine
DUNS #
948108063
City
San Juan
State
PR
Country
United States
Zip Code
00936
Cantres-Rosario, Yisel M; Acevedo-Mariani, Frances M; Pérez-Laspiur, Juliana et al. (2017) Microwave & magnetic proteomics of macrophages from patients with HIV-associated cognitive impairment. PLoS One 12:e0181779
Colon, Krystal; Perez-Laspiur, Juliana; Quiles, Raymond et al. (2016) Macrophage secretome from women with HIV-associated neurocognitive disorders. Proteomics Clin Appl 10:136-43
Vázquez-Santiago, Fabián J; Rivera-Amill, Vanessa (2015) Envelope gene evolution and HIV-1 neuropathogenesis. J Neuroinfect Dis 6:
Vázquez-Santiago, Fabián; García, Yashira; Rivera-Román, Ivelisse et al. (2015) Longitudinal Analysis of Cerebrospinal Fluid and Plasma HIV-1 Envelope Sequences Isolated From a Single Donor with HIV Asymptomatic Neurocognitive Impairment. J Virol Antivir Res 4:
Ríos, Grissel; Estrada, Marcos; Mayor, Angel M et al. (2014) Factors associated with tender point count in Puerto Ricans with fibromyalgia syndrome. P R Health Sci J 33:112-6
Gandhi, Rajesh T; Bosch, Ronald J; Aga, Evgenia et al. (2013) Residual plasma viraemia and infectious HIV-1 recovery from resting memory CD4 cells in patients on antiretroviral therapy: results from ACTG A5173. Antivir Ther 18:607-13
González, Lorena; Magno, Priscilla; Ortiz, Ana P et al. (2013) Esophageal cancer incidence rates by histological type and overall: Puerto Rico versus the United States Surveillance, Epidemiology, and End Results population, 1992-2005. Cancer Epidemiol 37:5-10
Murthy, Vijaya; Willis, Rohan; Romay-Penabad, Zurina et al. (2013) Value of isolated IgA anti-?2 -glycoprotein I positivity in the diagnosis of the antiphospholipid syndrome. Arthritis Rheum 65:3186-93
Suárez, Erick; González, Lorena; Díaz-Toro, Elba C et al. (2013) Incidence of oral cavity and pharyngeal cancers by anatomical sites in population-based registries in Puerto Rico and the United States of America. P R Health Sci J 32:175-81
Ortiz, Ana Patricia; Romaguera, Josefina; Pérez, Cynthia M et al. (2013) Human papillomavirus infection in women in Puerto Rico: agreement between physician-collected and self-collected anogenital specimens. J Low Genit Tract Dis 17:210-7

Showing the most recent 10 out of 189 publications